Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Decreased Toll-interacting protein and peroxisome proliferator-activated receptor gamma are associated with increased expression of Toll-like receptors in colon carcinogenesis
Publication

Publications

Decreased Toll-interacting protein and peroxisome proliferator-activated receptor gamma are associated with increased expression of Toll-like receptors in colon carcinogenesis

Title
Decreased Toll-interacting protein and peroxisome proliferator-activated receptor gamma are associated with increased expression of Toll-like receptors in colon carcinogenesis
Type
Article in International Scientific Journal
Year
2012
Authors
Pedro Pimentel-Nunes
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Goncalves, N
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Boal Carvalho, I
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Afonso, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Lopes, P
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Roncon-Albuquerque R Jr
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Soares, JB
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Cardoso, E
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Moreira Dias, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Leite-Moreira AF
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 65
Pages: 302-308
ISSN: 0021-9746
Other information
Authenticus ID: P-002-BR9
Abstract (EN): Background Animal data suggest that Toll-like receptors (TLR) may play an important role in colon carcinogenesis. Studies in humans to support that hypothesis are scarce. Aim To evaluate the expression of TLR2, TLR4 and TLR5, and the expression of several other related molecules, in different human colonic lesions. Methods Colon biopsy samples from normal mucosa, normal mucosa adjacent to lesion, adenoma or sporadic carcinoma were obtained from 35 consecutive patients undergoing colonoscopy. Quantification of TLR2, TLR4, TLR5, Toll-interacting protein (TOLLIP), peroxisome proliferator-activated receptor gamma (PPAR-gamma), nuclear factor kappa B, tumour necrosis factor (TNF) alpha, cyclooxygenase (COX) 1 and 2 mRNA was performed by real-time reverse transcription PCR. TLR2, TLR4 and TLR5 protein expression was quantified by immunohistochemistry. Results When compared with normal mucosa (1.0 arbitrary unit (AU)), adjacent normal mucosa presented higher expression of COX-2 (1.86 +/- 0.3 AU, p=0.01) and TNF alpha (1.44 +/- 0.18 AU, p=0.04) and lower TOLLIP expression (0.75 +/- 0.05 AU, p=0.004). Adenomas and carcinomas presented higher expression of COX-2 (1.63 +/- 0.27 and 1.38 +/- 0.14 AU, p=0.03 and p=0.05, respectively) and lower expression of TOLLIP (0.44 +/- 0.04 AU, p<0.001), with diffuse and higher TLR protein expression (p<0.001). Carcinomas also expressed higher TLR2 (2.31 +/- 0.32 AU, p=0.006) and lower PPAR-gamma (0.56 +/- 0.12 AU, p=0.003). There was a trend towards decreased TOLLIP (p<0.001) and PPAR-gamma (p=0.05) from normal mucosa to adenoma/carcinoma. Conclusions Persistently positive TLR expression and lower expression of TLR inhibitors was associated with higher TLR protein levels throughout the spectrum of lesions of colon carcinogenesis. Increasing activation of these receptors by bacteria may play a crucial role in colon carcinogenesis and tumour progression.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 7
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Pitfalls in diagnosing coeliac disease. (1995)
Another Publication in an International Scientific Journal
Dias, JA; Sousa, TR; Santos, M; Rodrigues, FC; Aguiar, A; Carneiro F; Teixeira, AV
PITFALLS IN DIAGNOSING CELIAC-DISEASE (1995)
Another Publication in an International Scientific Journal
DIAS, JA; SOUSA, TR; SANTOS, M; RODRIGUES, FC; AGUIAR, A; Carneiro F; TEIXEIRA, AV
IDIOPATHIC HEMOCHROMATOSIS IN NORTH PORTUGAL - ASSOCIATION WITH HAPLOTYPE A3B7 (1989)
Another Publication in an International Scientific Journal
Graca Porto; silva, bm; Corália Vicente; DESOUSA, M
Human herpes virus 6 causing myocarditis in a fetus: an infectious cause to a congenital heart defect (2011)
Another Publication in an International Scientific Journal
ramalho, c; Monterroso, J; Simoes, J; Brandao, O; Montenegro N
How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer (2009)
Another Publication in an International Scientific Journal
Pinto P Couto; Prazeres, H; Castro, P; Lima, J; Maximo, V; Soares, P; Sobrinho Simoes, M

See all (43)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-15 at 07:48:36 | Privacy Policy | Personal Data Protection Policy | Whistleblowing